Purchase Order HHSN272201200819P
Award Date 9/7/12
Potential Completion Date 9/30/12
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for $9,027.20. The contract, which has no set-aside designation, was awarded on April 27, 2011 for gene editing services to generate customized cell and animal models, including knockout mouse models, reporter cell lines, and stem cell models with disease-associated...
- This is a $23,500 Firm Fixed Price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for gene editing services. Applied Stemcell is a minority-owned, woman-owned small business that has previously provided gene editing services to various NIH institutes through federal contracts and grants. The award is for gene editing services to support NIAAA research...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. The contract is for $12,450.00 and has a completion date of September 24, 2019. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides gene editing services and GMP iPSC manufacturing to support cell-based research projects. Through past federal contract awards, the company has provided gene editing...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Applied Stemcell, Inc., a minority owned, woman owned small business. The $17,400.00 Firm Fixed Price contract is for the investigation of cellular dysfunction associated with hereditary mutation within the prion gene, insertion of the gene mutation (D178N) into a 'normal' cell background, with production of heterozygous insert...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for gene editing cell line services valued at $17,450 on August 14, 2019. The order was set aside for total small business. Performance occurs in Milpitas, California, with an ultimate completion date of October 25, 2019. The contract is firm fixed price.</p>
- This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Applied Stemcell, Inc., a minority-owned and woman-owned small business. The $24,115 contract is for NIDDK's F1 Breeding and Genotyping project, which involves gene editing services and GMP iPSC manufacturing to support cell-based research. Applied Stemcell has provided similar services to other...
- This firm fixed-price purchase order, valued at $22,000, was awarded by the National Institute of Child Health and Human Development (NICHD) to Applied Stemcell, Inc. for the provision of a large fragment knock-in mouse and related services. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that specializes in gene editing services and GMP-compliant iPSC manufacturing. This award was not set aside. Through past federal contracts and grants, Applied Stemcell has supplied gene...
- This is a $122,400.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business. The contract is for molecular and pathophysiological studies of Parkinson's disease dementia and does not have a set-aside designation. Applied Stemcell, Inc. provides gene editing services and good manufacturing practice (GMP) induced...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, to Applied Stemcell, Inc. for the generation of a conditional knockout mouse model using CRISPR/Cas9 gene editing technology. The award amount is $26,065.00, and the period of performance runs through July 19, 2021. The contract does not have a set-aside designation. Applied Stemcell is a minority-owned, woman-owned small...
- This is a $13,760 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. for the generation of point mutation induced pluripotent stem (iPS) or embryonic stem (ES) cell lines using CRISPR/Cas9 gene editing technology. The work is to be performed in Bethesda, MD and has a completion date of March 31, 2022. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides...
This is a $14,999.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Applied Stemcell, Inc. The contract is for applied gene editing services to support cell-based research projects, including the generation of customized cell and animal models. Applied Stemcell is a minority-owned, woman-owned small business that has previously received federal research grants and contract awards from agencies such as NIH, NIAID, NIDDK, NICHD, and NIA. This particular award was not set aside and appears to be part of the company's ongoing work providing specialized biotechnology services to the federal government.
Generated 11/24/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 9/7/12 |